BP000144-CYT-136: Recombinant Mouse Interleukin-1 Receptor Antagonist Protein (IL-1RA), His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGEBP000163-CYT-643: Recombinant Rat Interleukin-17F (IL-17F) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000163-CYT-587: Recombinant Human Interleukin-17F (IL-17F) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000163-CYT-642: Recombinant Mouse Interleukin-17F (IL-17F) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000140-CYT-542: Recombinant Rat Interleukin-17 (IL-17) Protein
Source: E. coli-derived.
Rat IL-17A is fully biologically active when compared to standards via dose-dependent induction of IL-6 production in cultured mouse NIH 3T3 fibroblasts. The ED50 for recombinant rat IL-17A in this assay was 30 ng/ml. The Specific Activity is 33333.33 units/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000140-CYT-378: Recombinant Mouse Interleukin-17 (IL-17) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant induction of IL-6 production in cultured mouse NIH 3T3 fibroblasts was found to be 0.4 ng/ml, corresponding to a specific activity of 2,500,000 units/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000140-CYT-662: Recombinant Human Interleukin-17 (IL-17) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000138-CYT-559: Recombinant Mouse Interleukin-16 (IL-16) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000138-CYT-536: Recombinant Human Interleukin-16 (130 a.a.) Protein
Source: E. coli-derived.
The ED50 as determined by its ability to chemoattract human CD4+ T lymphocytes using a concentration range of 10-100 ng/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000138-CYT-562: Recombinant Human Interleukin-16 (IL-16) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.